ACR

ACRES Commercial Realty Corp.
CAPPED RATING

ACRES Commercial Realty Corp., a real estate investment trust (REIT), focuses on the origination, holding, and management of commercial real estate mortgage loans and other commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including floating and fixed rate first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments, commercial mortgage-backed securities, and commercial real estate equity and preferred equity investments. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income tax to the extent that it distributes 100% of its REIT taxable income. The company was formerly known as Exantas Capital Corp. and changed its name to ACRES Commercial Realty Corp. in February 2021. ACRES Commercial Realty Corp. was incorporated in 2005 and is based in Uniondale, New York.

ACRES Commercial Realty Corp. (ACR) is rated C (2.2/5) on Deltasharpe Prism, scored against Real Estate sector peers. Its strongest pillar is Value (B+); its weakest is Momentum (F). The rating has held at C for 7 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.2 / 5.0
C
Value
B+
Factor Score 3.6 / 5.0
Growth
B-
Factor Score 3.0 / 5.0
Profitability
D+
Factor Score 1.7 / 5.0
Momentum
F
Factor Score 0.4 / 5.0
Revisions
C
Factor Score 2.4 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 6.6
EV / EBITDA N/A
Rev Growth YoY N/A
Gross Margin 13.2%
Price Return 3M -41.8%
Price Return 12M -59.7%
Catalyst Signal 0.00
Market Cap $116.2M
TTM Revenue $56.2M
Price / Sales 2.1
ROE -4.8%

Historical Factor Score Progression

Held C for 7 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 B+ (3.6) B- (3.0) D+ (1.7) F (0.4) C (2.4) C (2.2)
2026-11-10 B (3.4) C+ (2.8) D+ (1.7) D (1.2) C (2.4) C (2.3)
2026-11-03 B (3.5) C (2.3) C (2.4) D (1.4) C (2.4) C (2.4)
2026-10-27 B+ (3.5) C (2.2) C (2.4) F (0.4) C (2.4) C (2.2)
2026-10-20 B+ (3.6) C (2.2) C (2.4) F (0.6) C (2.4) C (2.2)
Page 1 of 4